Nanotechnological applications of marine algae derived neurotoxins spanning harmful algal blooms and therapeutic innovations Authors: Morteza Golbashirzadeh Published: 2026 ABSTRACT Marine algae-derived neurotoxins, commonly associated with harmful algal blooms (HABs), represent a paradox in marine and biomedical sciences. While traditionally studied for their ecological disruptions and health hazards, these bioactive compounds possess unique biochemical properties with promising therapeutic and technological applications. By summarizing current knowledge and identifying gaps in research, this review systematically examines the biological significance of marine algae, elucidates the mechanisms underlying neurotoxin production, and assesses their biomedical relevance. Furthermore, it explores nanotechnology as a transformative approach for harnessing neurotoxins in drug delivery, biosensing, and theranostics. Particular emphasis is placed on nano-biosensors for precise neurotoxin detection, nanomaterial-based mitigation strategies for HABs, and the use of neurotoxin-loaded nanocarriers in targeted pharmacological interventions. Ethical and environmental considerations surrounding neurotoxin utilization are critically analyzed to ensure sustainable applications. By synthesizing current knowledge and identifying gaps in research, this review hypothesizes that marine algae-derived neurotoxins, when incorporated into nanosystems, can serve as multifunctional agents in precision medicine, neuropharmacology, and diagnostic imaging. Through an interdisciplinary perspective bridging marine biology, toxicology, and nanoscience, this work aims to provide a structured framework for future research, fostering innovation at the intersection of marine biotechnology and nanomedicine. Introduction Marine algae serve as foundational components of aquatic ecosystems, playing a pivotal role in primary productivity, nutrient cycling, and oxygen generation [1]. These photosynthetic organisms contribute significantly to global carbon sequestration while supporting complex marine food webs. Their diverse biochemical profiles allow them to adapt to varied environmental conditions, ranging from open oceanic waters to nutrient-rich coastal systems [2, 3]. Despite their ecological importance, certain algae species can undergo excessive proliferation, leading to harmful algal blooms (HABs). These events, often triggered by rising ocean temperatures, nutrient influx, and hydrodynamic shifts, can have devastating consequences for marine biodiversity, fisheries, and human health [4]. Because harmful algal blooms (HABs) occur unpredictably, ongoing ecological surveillance is essential. These events disrupt aquatic food chains and generate potent neurotoxins that accumulate in marine organisms, creating significant risks for both human consumption and long‑term environmental sustainability. However, the problem lies in the dual nature of marine algae-derived neurotoxins: while they are hazardous compounds responsible for ecological damage and human intoxications, they also possess unique biochemical properties that can be harnessed for biomedical innovation. Therefore, although HABs are widely recognized for their detrimental effects, marine algae also harbor untapped potential in biotechnology [5]. Their secondary metabolites, including neurotoxins, offer opportunities for applications beyond environmental hazards, particularly in drug development, nanomedicine, and biosensing technologies. As scientific interest in algae-derived biomolecules grows, there is an urgent need to explore both their adverse effects and their transformative potential in biomedical innovation [5]. This gap thus presents an opportunity to reframe neurotoxins not only as threats but also as valuable biomolecules with translational potential, making the topic both scientifically significant and attractive to a broad readership. Neurotoxic compounds produced by marine algae, including saxitoxins, brevetoxins, and domoic acid, exhibit highly specific biochemical interactions that affect neurological function [6]. These toxins primarily act on voltage-gated ion channels and neurotransmitter receptors, leading to severe disruptions in neuronal communication. While their toxicity poses significant concerns for marine ecosystems and human health, recent advances in neuroscience have recognized their potential utility as research tools and therapeutic agents. For instance, saxitoxin functions as a selective sodium channel blocker, making it a valuable tool for studying neuronal excitability and nerve conduction disorders. Likewise, brevetoxins modulate sodium channel kinetics, offering insight into neuroinflammatory mechanisms and disease pathology [7]. Domoic acid, known for its glutamate receptor agonist activity, has been utilized to model excitotoxicity in Alzheimer’s disease and epilepsy research. Consequently, The ability of these neurotoxins to precisely target neural pathways has opened new avenues in pharmacology, particularly in drug development for neurodegenerative conditions, chronic pain management, and synaptic modulation therapies [8]. Despite their therapeutic promise, challenges remain in regulating neurotoxin bioactivity and ensuring controlled application in medical contexts. Continued research must therefore focus on refining delivery mechanisms and minimizing unintended toxicity while optimizing pharmacological benefits. Nanotechnology has emerged as a transformative tool for enhancing the functionality and safety of marine neurotoxins in biomedical applications [9]. By incorporating neurotoxin molecules into nanoscale carriers, researchers can regulate their bioavailability, improve their therapeutic precision, and mitigate toxicity concerns. Nanocarriers such as liposomes, polymeric nanoparticles, and metallic nanostructures have demonstrated potential for encapsulating and delivering neurotoxins in controlled doses, ensuring optimal pharmacological outcomes while preventing off-target effects [10, 11]. Beyond drug delivery, nanotechnology plays a crucial role in biosensing applications, allowing for the rapid and sensitive detection of marine neurotoxins in seafood, water samples, and environmental monitoring systems. Nano-enabled biosensors utilize highly specific recognition elements to bind neurotoxic molecules, generating quantifiable signals that facilitate timely toxin detection. These platforms are instrumental in public health initiatives, mitigating seafood contamination risks while improving HAB surveillance strategies [12, 13]. In theranostics the integration of therapeutic and diagnostic functions—marine neurotoxins encapsulated within nanocarriers have demonstrated potential for precision medicine. The significance of this review lies in addressing the current gap: despite extensive research on HABs and neurotoxin biosynthesis, systematic exploration of their integration within nanotechnological frameworks is still in its infancy. This work aims to provide a structured perspective on how marine algae‑derived neurotoxins can be transformed from ecological hazards into multifunctional agents for biomedical innovation. By critically analyzing existing knowledge, identifying research gaps, and proposing interdisciplinary strategies, this review seeks to attract attention to an emerging frontier at the intersection of marine biology, toxicology, and nanomedicine. Harmful algal blooms (HABs) and neurotoxin production Overview of HABs and their global significance Harmful algal blooms (HABs) are rapid proliferations of algae, particularly microalgae, in aquatic ecosystems that lead to significant environmental and health impacts. While algal blooms occur naturally, human activities such as nutrient pollution, climate change, and water temperature fluctuations have intensified their frequency and severity [14]. From a technical perspective, HABs are characterized by high cell densities, often exceeding 106 cells per liter, which can result in hypoxic or anoxic conditions in affected waters. The proliferation is typically driven by eutrophication, where excess nitrogen and phosphorus inputs accelerate algal growth. Physical parameters such as water column stratification, salinity gradients, and light penetration also play critical roles in bloom initiation and persistence. Consequently Monitoring programs often rely on chlorophyll-a concentration as a proxy for algal biomass, with thresholds above 10 µg/L commonly used to indicate bloom conditions [15]. Globally, HABs pose a major ecological and economic concern. In coastal waters, they disrupt marine food webs, deplete oxygen levels, and contribute to mass fish kills. Moreover, they affect industries reliant on seafood, tourism, and recreation [16]. Economic losses from HABs are estimated in the billions annually, due to fisheries closures, aquaculture damage, and healthcare costs associated with toxin exposure [17]. Some species involved in HABs produce potent neurotoxins that accumulate in seafood and pose direct threats to human health. These toxins, such as saxitoxins and domoic acid, are responsible for severe neurological disorders when consumed, leading to widespread health warnings and regulatory interventions [18]. In addition to direct toxicity, In addition to direct toxicity, HABs can cause secondary impacts such as biofouling of aquaculture systems, alteration of benthic habitats, and long-term shifts in ecosystem structure. Finally Technical advances in remote sensing, molecular diagnostics, and in situ biosensors are increasingly being applied to detect HABs early, quantify toxin concentrations, and predict bloom trajectories. Such tools are critical for mitigating risks and informing management strategies at regional and global scales [19]. Biochemical pathways of neurotoxin synthesis in marine algae The biosynthesis of neurotoxins in marine algae is a highly intricate and evolutionarily refined process, governed by specialized metabolic pathways that vary significantly among species. For example, Toxin-producing microalgae, including Alexandrium, Karenia, and Pseudonitzschia, employ diverse enzymatic mechanisms to convert primary metabolites into potent neurotoxic compounds. These pathways are not only species-specific but are also influenced by a complex interplay of genetic, biochemical, and environmental factors [20, 21]. A well-studied example is the synthesis of saxitoxins paralytic shellfish toxins predominantly produced by dinoflagellates of the genus Alexandrium [22]. The biosynthetic pathway begins with arginine and other amino acid precursors, which undergo a series of enzymatic transformations, including methylation, oxidation, and cyclization, ultimately yielding a suite of structurally related neurotoxic alkaloids. Figure 1 provides an overview of saxitoxin-producing organisms, including cyanobacterial genera such as Aphanizomenon, Dolichospermum, and Cylindrospermopsis, as well as marine dinoflagellates like Alexandrium and Gymnodinium. The figure further highlights the neurotoxic mechanism of saxitoxin, depicting its interaction with voltage-gated calcium channels, where it contributes to disrupted calcium ion flux and altered neuronal communication. This complements its established role in blocking voltage-gated sodium channels, emphasizing its broader influence on excitable cell signaling.Fig. 1Representative overview of saxitoxin-producing organisms and the neurotoxic effects of saxitoxin on calcium channels. The figure illustrates key cyanobacterial genera (e.g.,Aphanizomenon, Dolichospermum, Cylindrospermopsis) and marine dinoflagellates (e.g., Alexandrium, Gymnodinium) known to biosynthesize saxitoxin. Saxitoxin, a potent neurotoxin, is shown interacting with voltage-gated calcium channels, contributing to disrupted ion flux and impaired neuronal signaling. This mechanism complements its well-documented blockade of sodium channels, highlighting its broader impact on excitable cells Representative overview of saxitoxin-producing organisms and the neurotoxic effects of saxitoxin on calcium channels. The figure illustrates key cyanobacterial genera (e.g.,Aphanizomenon, Dolichospermum, Cylindrospermopsis) and marine dinoflagellates (e.g., Alexandrium, Gymnodinium) known to biosynthesize saxitoxin. Saxitoxin, a potent neurotoxin, is shown interacting with voltage-gated calcium channels, contributing to disrupted ion flux and impaired neuronal signaling. This mechanism complements its well-documented blockade of sodium channels, highlighting its broader impact on excitable cells Similarly, a neurotoxin associated with amnesic shellfish poisoning synthesized by diatoms of the genus Pseudo- nitzschia via polyketide biosynthesis. This process involves the stepwise assembly of acetate and malonate units, followed by subsequent modifications that confer the molecule’s neuroactive properties (Fig. 1) [23]. Environmental situationplays a pivotal role in modulating neurotoxin production. Fluctuations in nutrient concentrationsparticularly nitrogen and phosphorusalong with variations in salinity, pH, and temperature, can induce transcriptional changes in genes encoding key biosynthetic enzymes. These regulatory mechanisms often lead to increased toxin production during algal blooms, suggesting an adaptive ecological function, such as predator deterrence or competitive advantage. Understanding these biochemical pathways is essential not only for elucidating the ecological role of algal neurotoxins but also for developing strategies to mitigate their impacts on marine ecosystems and human health [24–26]. Challenges posed by neurotoxins and HABs to ecosystems and human health The presence of HAB-related neurotoxins has far-reaching implications for marine ecosystems, human health, and economic stability. In aquatic environments, neurotoxins disrupt food chains by affecting grazers such as zooplankton and filter-feeding shellfish, leading to bioaccumulation in higher trophic levels. This can result in widespread mortality among marine organisms, including fish and seabirds [27, 28]. From a human health perspective, exposure to neurotoxins via contaminated seafood or aerosolized HAB particles can cause debilitating neurological symptoms. Paralytic shellfish poisoning (PSP), amnesic shellfish poisoning (ASP), and neurotoxic shellfish poisoning (NSP) are severe conditions linked to toxin ingestion. These illnesses range from mild gastrointestinal distress to life-threatening respiratory paralysis or permanent neurological damage. The unpredictability of HAB occurrences complicates regulatory efforts and necessitates continuous monitoring of coastal waters [29]. Beyond their impact on public health, harmful algal blooms (HABs) impose significant socioeconomic burdens. Fisheries suffer substantial losses due to stock contamination, while coastal communities experience declines in tourism revenue. Therefore, Effectively addressing these challenges necessitates interdisciplinary strategies that integrate ecological monitoring, public health interventions, and targeted mitigation efforts to manage bloom triggers [30]. Nanotechnology in neurotoxin detection Development of nano-biosensors for rapid and accurate detection of neurotoxins The application of nanotechnology in neurotoxin detection has led to the development of highly sensitive nano-biosensors, which significantly enhance the efficiency and accuracy of toxin monitoring. Traditional detection methods, including high-performance liquid chromatography (HPLC) and enzyme-linked immunosorbent assays (ELISA), are effective but often time-consuming, requiring sophisticated laboratory equipment and trained personnel. In contrast, nano-biosensors provide several distinct advantages, including real-time detection capabilities, superior sensitivity, portability, and the potential for multiplexed analysis of multiple neurotoxins simultaneously [31]. These platforms are particularly valuable for routine monitoring of coastal waters, rapid response during HAB events, and point-of-care testing for seafood safety. The working principle of nano-biosensors relies on the integration of nanomaterials with specific bio-recognition elements to convert toxin-analyte interactions into measurable signals. Three main transduction mechanisms are commonly employed: electrochemical, optical, and piezoelectric [32]. Electrochemical biosensors measure current or impedance changes resulting from neurotoxin binding to electrode surfaces modified with nanomaterials such as gold nanoparticles or grapheme [33]. Optical biosensors, including surface plasmon resonance (SPR) and fluorescence-based systems, detect toxin-induced alterations in light absorption or emission. Piezoelectric sensors utilize quartz crystal microbalance technology to measure mass changes upon toxin capture. Each mechanism offers unique advantages depending on the target neurotoxin, sample matrix, and desired detection limit [34]. These biosensors integrate nanomaterials such as gold nanoparticles, graphene-based structures, and quantum dots to facilitate signal amplification and improve molecular interactions with neurotoxins [35]. The high surface-area-to-volume ratio of these nanomaterials provides abundant binding sites for bio-recognition elements, while their unique electronic and optical properties enable signal amplification down to single-molecule detection levels. Additionally, bio-recognition elements such as aptamers, antibodies, and enzymes allow selective binding to neurotoxins, triggering quantifiable responses that ensure precise identification [36]. Among these, aptamers short, single-stranded DNA or RNA sequences have gained particular attention due to their high stability, low cost of synthesis, and excellent reproducibility compared to traditional antibodies. Recent studies demonstrate that nano‑biosensors can detect marine neurotoxins at extremely low concentrations, with detection limits reported as low as 0.5–5 nM for saxitoxin, 0.1 nM for domoic acid, and even femtomolar levels for botulinum neurotoxin using nanostructured electrodes and aptamer‑based platforms [37, 38]. These values represent a 10–1000‑fold improvement over conventional assays. For context, regulatory safety limits for saxitoxin in seafood are typically set at 80 µg/kg (approximately 160 nM), meaning that current nano-biosensor detection limits are well below regulatory thresholds, offering a substantial safety margin for public health monitoring. The ability to detect neurotoxins at such low concentrations enables early warning of contamination before toxins reach dangerous levels, potentially preventing human poisoning events. Portability is another major advantage, as many nano‑biosensors are now integrated into handheld electrochemical readers, paper‑based microfluidic chips, and smartphone‑connected optical devices weighing less than 200 g, enabling rapid on‑site detection without laboratory infrastructure [39, 40].These portable platforms have been successfully field-tested in various marine environments, demonstrating their practicality for routine monitoring by non-specialized personnel. However, challenges remain in terms of long-term sensor stability, matrix interference from complex environmental samples, and calibration requirements. Current research is actively addressing these limitations through the development of self-calibrating sensor arrays, microfluidic sample pre-treatment modules, and machine learning algorithms for signal interpretation [41–43] (Table 1).Table 1Fundamental advantages of nano-biosensors in neurotoxin detection. this table comprehensively summarizes the advantages of nano-biosensors in neurotoxin detection, highlighting their role in improving sensitivity, specificity, and efficiency in environmental and biomedical applicationsFeatureScientific advantagesExample neurotoxin & concentration rangeReferenceHigh sensitivityEnables detection of neurotoxins at trace concentrations, improving early warning capabilitiesSaxitoxin (STX): detection limit ~ 0.1–1 ng/mL[41, 44]Rapid detectionReduces analysis time, allowing real-time monitoring in marine environmentsDomoic Acid: detection within 10–15 min[31, 45]PortabilityCompact sensor designs facilitate field deployment for on-site testingBrevetoxin: portable assays detect < 5 ng/mL[46, 47]Cost efficiencyMinimizes reliance on expensive laboratory infrastructure, making monitoring more accessibleGeneral application across HAB toxins[31, 48, 49]SelectivityUtilizes highly specific recognition elements such as aptamers and antibodies to distinguish neurotoxins from other contaminantsMicrocystin-LR: aptamer-based selectivity[49–51]MiniaturizationEnables the development of small-scale, integrated biosensors for on-site and point-of-care applicationsCylindrospermopsin: chip-based detection[52–54]Multiplexing capabilityAllows simultaneous detection of multiple neurotoxins, improving diagnostic efficiencySTX + DA multiplex assays[55, 56]Real-time monitoringProvides continuous assessment of neurotoxin levels, facilitating early intervention strategiesHAB toxins monitored continuously[48, 57]Eco-friendly designReduces chemical waste and environmental impact compared to conventional detection methodsGeneral application[41, 58, 59] Table 1Fundamental advantages of nano-biosensors in neurotoxin detection. this table comprehensively summarizes the advantages of nano-biosensors in neurotoxin detection, highlighting their role in improving sensitivity, specificity, and efficiency in environmental and biomedical applicationsFeatureScientific advantagesExample neurotoxin & concentration rangeReferenceHigh sensitivityEnables detection of neurotoxins at trace concentrations, improving early warning capabilitiesSaxitoxin (STX): detection limit ~ 0.1–1 ng/mL[41, 44]Rapid detectionReduces analysis time, allowing real-time monitoring in marine environmentsDomoic Acid: detection within 10–15 min[31, 45]PortabilityCompact sensor designs facilitate field deployment for on-site testingBrevetoxin: portable assays detect < 5 ng/mL[46, 47]Cost efficiencyMinimizes reliance on expensive laboratory infrastructure, making monitoring more accessibleGeneral application across HAB toxins[31, 48, 49]SelectivityUtilizes highly specific recognition elements such as aptamers and antibodies to distinguish neurotoxins from other contaminantsMicrocystin-LR: aptamer-based selectivity[49–51]MiniaturizationEnables the development of small-scale, integrated biosensors for on-site and point-of-care applicationsCylindrospermopsin: chip-based detection[52–54]Multiplexing capabilityAllows simultaneous detection of multiple neurotoxins, improving diagnostic efficiencySTX + DA multiplex assays[55, 56]Real-time monitoringProvides continuous assessment of neurotoxin levels, facilitating early intervention strategiesHAB toxins monitored continuously[48, 57]Eco-friendly designReduces chemical waste and environmental impact compared to conventional detection methodsGeneral application[41, 58, 59] Fundamental advantages of nano-biosensors in neurotoxin detection. this table comprehensively summarizes the advantages of nano-biosensors in neurotoxin detection, highlighting their role in improving sensitivity, specificity, and efficiency in environmental and biomedical applications These advancements are instrumental in environmental monitoring, seafood safety assessment, and public health protection, enabling proactive responses to harmful algal blooms (HABs) [60]. Integration of marine algae-derived compounds into nanomaterials for enhanced sensitivity Marine algae produce a diverse array of bioactive compounds that have demonstrated significant potential in improving the functional properties of nanomaterials. Polysaccharides, proteins, and secondary metabolites derived from algae enhance the stability, selectivity, and binding efficiency of nano-biosensors, thereby increasing their overall sensitivity to neurotoxins [61, 62]. The fundamental rationale behind this integration lies in the unique physicochemical properties of algae-derived biomolecules, including their high density of functional groups (e.g., hydroxyl, carboxyl, and sulfate moieties), which facilitate strong interactions with both nanomaterial surfaces and target toxin molecules [63]. These functional groups enable covalent conjugation, electrostatic adsorption, and hydrogen bonding, creating stable and reproducible sensor interfaces [64]. Compounds such as fucoidan (derived from brown algae) and carrageenan (extracted from red algae) exhibit strong biocompatibility and have been successfully incorporated into nanomaterials to optimize toxin detection. These biomolecules facilitate effective interactions between the sensor surface and neurotoxins, leading to improved analytical performance. Fucoidan, a sulfated polysaccharide, contains fucose residues and sulfate ester groups that confer negative charge and high water solubility, making it particularly effective at binding positively charged toxin molecules through electrostatic interactions. Carrageenan, another sulfated polysaccharide, forms helical structures in solution that create binding pockets for small-molecule neurotoxins, enhancing capture efficiency [65, 66]. Several studies have successfully performed this integration. For example, fucoidan from brown algae has been incorporated into biosensor platforms for microcystin-LR detection, achieving limits as low as ~ 0.05 ng/mL [67, 68]. This detection limit is approximately two orders of magnitude lower than the World Health Organization’s provisional guideline value of 1 µg/L for microcystin-LR in drinking water, demonstrating the practical utility of algae-enhanced biosensors for regulatory compliance monitoring [69]. Beyond fucoidan and carrageenan, other algae-derived compounds have also shown promise. Alginate, a polysaccharide from brown algae, has been used to encapsulate nanomaterials in hydrogel matrices, providing three-dimensional sensor architectures with enhanced surface area and analyte accessibility. Phycobiliproteins (e.g., phycoerythrin and phycocyanin) from red and blue-green algae exhibit natural fluorescence properties, enabling their use as optical reporters in fluorescence-based biosensing platforms. Peptides derived from algal proteins have been employed as molecular recognition elements, offering specificity comparable to antibodies but with greater stability and lower production costs [70, 71] (Table 2).Table 2Functional contributions of algae-derived compounds to nanotechnology-based neurotoxin detectionAlgae-derived compoundRole in nano-sensorsExample neurotoxin & detection limitRefFucoidan (brown algae)Enhances bio-recognition processes, improving neurotoxin-binding efficiencyMicrocystin-LR: detection limit ~ 0.05 ng/mL using fucoidan-modified biosensor[67, 72]Carrageenan (red algae)Strengthens sensor stability and supports surface modifications for increased accuracyκ-Carrageenan biosensor applied for toxin-binding stability; detection in μg/mL range[68, 73]Marine-derived peptidesFacilitates molecular interactions, boosting specificity in toxin identificationTetrodotoxin (TTX): peptide-based biosensor detection limit ~ 1 ng/mL[74–76]Algal polysaccharidesImproves sensor adhesion, enhancing overall sensitivity and signal strengthGeneral HAB toxins: polysaccharide coatings improve adhesion and sensitivity[33, 77]Alginate (brown algae)Provides structural integrity to nanoparticles, improving biocompatibility and controlled releaseMicrocystin-LR: alginate nanoparticle biosensor detection limit ~ 0.1 ng/mL[77, 78]Phycobiliproteins (red algae)Enhances fluorescence-based biosensing, improving signal detection for neurotoxin identificationFluorescence biosensor for saxitoxin (STX): detection limit ~ 0.5 ng/mL using phycobiliproteins[79–81]Sulfated polysaccharidesModulates nanoparticle surface charge, optimizing interactions with neurotoxic moleculesNeuroprotective biosensor coatings for cyanotoxins; detection in ng/mL range[8, 82–84]Carotenoids (green and red algae)Acts as antioxidant stabilizers, preventing oxidative degradation of biosensor componentsBotulinum neurotoxin A: portable biosensor assay detection limit ~ 1 ng/mL[85–87] Table 2Functional contributions of algae-derived compounds to nanotechnology-based neurotoxin detectionAlgae-derived compoundRole in nano-sensorsExample neurotoxin & detection limitRefFucoidan (brown algae)Enhances bio-recognition processes, improving neurotoxin-binding efficiencyMicrocystin-LR: detection limit ~ 0.05 ng/mL using fucoidan-modified biosensor[67, 72]Carrageenan (red algae)Strengthens sensor stability and supports surface modifications for increased accuracyκ-Carrageenan biosensor applied for toxin-binding stability; detection in μg/mL range[68, 73]Marine-derived peptidesFacilitates molecular interactions, boosting specificity in toxin identificationTetrodotoxin (TTX): peptide-based biosensor detection limit ~ 1 ng/mL[74–76]Algal polysaccharidesImproves sensor adhesion, enhancing overall sensitivity and signal strengthGeneral HAB toxins: polysaccharide coatings improve adhesion and sensitivity[33, 77]Alginate (brown algae)Provides structural integrity to nanoparticles, improving biocompatibility and controlled releaseMicrocystin-LR: alginate nanoparticle biosensor detection limit ~ 0.1 ng/mL[77, 78]Phycobiliproteins (red algae)Enhances fluorescence-based biosensing, improving signal detection for neurotoxin identificationFluorescence biosensor for saxitoxin (STX): detection limit ~ 0.5 ng/mL using phycobiliproteins[79–81]Sulfated polysaccharidesModulates nanoparticle surface charge, optimizing interactions with neurotoxic moleculesNeuroprotective biosensor coatings for cyanotoxins; detection in ng/mL range[8, 82–84]Carotenoids (green and red algae)Acts as antioxidant stabilizers, preventing oxidative degradation of biosensor componentsBotulinum neurotoxin A: portable biosensor assay detection limit ~ 1 ng/mL[85–87] Functional contributions of algae-derived compounds to nanotechnology-based neurotoxin detection highlighting that integration has already been demonstrated across multiple toxin classes. These examples confirm that algae‑derived biomolecules are not only theoretically promising but have been practically incorporated into nanomaterials, resulting in measurable improvements in biosensor performance. Such advancements hold promising applications for environmental monitoring, food safety, and biomedical research, contributing to innovative strategies for mitigating HAB‑related risks [88]. Nano-based mitigation strategies for harmful algal blooms (HABs) Use of nanotechnology in environmental monitoring and HAB management The integration of nanotechnology in environmental monitoring and HAB management has emerged as a transformative approach to detecting, controlling, and mitigating the adverse effects of harmful algal blooms. Traditional monitoring techniques, such as satellite imaging and water sampling, provide valuable data but often lack real-time sensitivity and precision. Nanotechnology offers innovative solutions by enhancing detection accuracy, enabling early intervention, and minimizing ecological disruptions [89, 90]. Nano-sensors, which utilize nanomaterials such as carbon nanotubes, quantum dots, and metal oxide nanoparticles, provide highly sensitive platforms for monitoring HAB-related parameters. These sensors can detect minute changes in water chemistry, including nutrient concentrations and algal toxin levels, allowing for timely responses to bloom developments. Furthermore, nano-based fluorescence and electrochemical sensors facilitate rapid identification of neurotoxins, improving risk assessment and management strategies for affected ecosystems [89, 91, 92]. Another critical application of nanotechnology is the development of nano-enabled remediation systems. By engineering nanostructures capable of binding and neutralizing algal toxins, researchers aim to mitigate the ecological and health hazards posed by HABs. Functionalized nanoparticles with high affinity for neurotoxins can remove contaminants from aquatic systems, reducing their bioavailability and toxic impact [93, 94] (Table 3).Table 3Applications of nanotechnology in environmental monitoring and HAB managementNanotechnology applicationFunction in HAB monitoring and managementExample neurotoxin & detection limitReferencesNano-sensorsDetects environmental changes and toxin presence with high sensitivity, enabling early intervention strategiesSaxitoxin (STX): aptamer-based nanosensor detection limit ~ 0.1 ng/mL[44, 95]Quantum dot fluorescence sensorsProvides real-time visualization of HAB-associated toxins, improving detection accuracy in aquatic environmentsDomoic Acid: quantum dot biosensor detection limit ~ 0.5 ng/mL[96–99]Electrochemical nano-sensorsEnables precise quantification of neurotoxin concentrations, facilitating rapid risk assessment and mitigationMicrocystin-LR: electrochemical aptasensor detection limit ~ 0.05 ng/mL[49, 100, 101]Nano-Enabled RemediationNeutralizes and removes algal toxins from aquatic ecosystems, reducing bioavailability and toxic impactCylindrospermopsin: photocatalytic degradation using TiO₂ nanoparticles[54, 102]Nanoparticle-based adsorbentsUtilizes functionalized nanoparticles to capture and degrade algal toxins, preventing their accumulation in marine food chainsMicrocystin-LR: adsorption using graphene oxide nanoparticles, detection limit ~ 0.1 ng/mL[78, 103]Magnetic nanoparticlesFacilitates toxin removal through magnetic separation techniques, enhancing water purification processesBrevetoxin: removal efficiency 90% using Fe₃O₄ nanoparticles[89, 104]Nano-coatings for sensorsEnhances sensor durability and sensitivity, ensuring long-term monitoring of HAB-related parametersMicrocystin-LR: nano-coating improved stability and detection limit ~ 0.05 ng/mL[57, 105]DNA-based nano-biosensorsDetects HAB species at the genetic level, enabling early identification and predictive modeling of bloom eventsKarenia brevis (brevetoxin-producing species): DNA biosensor detection limit ~ 10 copies/µL[106]Nano-photocatalystsDegrades algal toxins through photocatalytic reactions, reducing their persistence in aquatic environmentsMicrocystin-LR: photocatalytic degradation using TiO₂ nanomaterials[107]Smart nanomaterials for HAB controlDevelops responsive nanomaterials that inhibit algal proliferation, preventing bloom formation without harming non-target organismsCylindrospermopsisraciborskii: smart nanomaterials suppress bloom formation[84, 108, 109] Table 3Applications of nanotechnology in environmental monitoring and HAB managementNanotechnology applicationFunction in HAB monitoring and managementExample neurotoxin & detection limitReferencesNano-sensorsDetects environmental changes and toxin presence with high sensitivity, enabling early intervention strategiesSaxitoxin (STX): aptamer-based nanosensor detection limit ~ 0.1 ng/mL[44, 95]Quantum dot fluorescence sensorsProvides real-time visualization of HAB-associated toxins, improving detection accuracy in aquatic environmentsDomoic Acid: quantum dot biosensor detection limit ~ 0.5 ng/mL[96–99]Electrochemical nano-sensorsEnables precise quantification of neurotoxin concentrations, facilitating rapid risk assessment and mitigationMicrocystin-LR: electrochemical aptasensor detection limit ~ 0.05 ng/mL[49, 100, 101]Nano-Enabled RemediationNeutralizes and removes algal toxins from aquatic ecosystems, reducing bioavailability and toxic impactCylindrospermopsin: photocatalytic degradation using TiO₂ nanoparticles[54, 102]Nanoparticle-based adsorbentsUtilizes functionalized nanoparticles to capture and degrade algal toxins, preventing their accumulation in marine food chainsMicrocystin-LR: adsorption using graphene oxide nanoparticles, detection limit ~ 0.1 ng/mL[78, 103]Magnetic nanoparticlesFacilitates toxin removal through magnetic separation techniques, enhancing water purification processesBrevetoxin: removal efficiency 90% using Fe₃O₄ nanoparticles[89, 104]Nano-coatings for sensorsEnhances sensor durability and sensitivity, ensuring long-term monitoring of HAB-related parametersMicrocystin-LR: nano-coating improved stability and detection limit ~ 0.05 ng/mL[57, 105]DNA-based nano-biosensorsDetects HAB species at the genetic level, enabling early identification and predictive modeling of bloom eventsKarenia brevis (brevetoxin-producing species): DNA biosensor detection limit ~ 10 copies/µL[106]Nano-photocatalystsDegrades algal toxins through photocatalytic reactions, reducing their persistence in aquatic environmentsMicrocystin-LR: photocatalytic degradation using TiO₂ nanomaterials[107]Smart nanomaterials for HAB controlDevelops responsive nanomaterials that inhibit algal proliferation, preventing bloom formation without harming non-target organismsCylindrospermopsisraciborskii: smart nanomaterials suppress bloom formation[84, 108, 109] Applications of nanotechnology in environmental monitoring and HAB management These advancements underscore the potential of nanotechnology in proactive HAB management, reducing ecological damage while safeguarding public health [5, 89]. Novel nanomaterials for neutralizing neurotoxins in aquatic systems Beyond monitoring capabilities, nanotechnology plays a crucial role in the direct mitigation of neurotoxin contamination. The development of engineered nanomaterials capable of neutralizing harmful algal toxins presents a promising strategy for minimizing their impact on marine ecosystems and human health [110]. Nanoparticles with surface modifications designed for toxin adsorption and degradation offer targeted solutions for toxin removal. For instance, metal-based nanostructures, such as titanium dioxide and silver nanoparticles, have been explored for their ability to degrade neurotoxic compounds through photocatalytic and oxidative processes [111, 112]. Additionally, functionalized carbon-based nanomaterials, including graphene and activated carbon nanoparticles, exhibit strong adsorption properties, effectively capturing and sequestering algal toxins from water bodies [113]. The following table (Table 4) outlines key nanomaterials utilized in neurotoxin neutralization, including representative toxins and detection/mitigation ranges reported in peer-reviewed studies:Table 4The following table outlines key nanomaterials utilized in neurotoxin neutralization:NanomaterialMechanism of neurotoxin mitigationExample neurotoxin & detection/mitigation rangeRefTitanium dioxide nanoparticlesPhotocatalytic degradation of neurotoxins under light exposureMicrocystin-LR: photocatalytic degradation efficiency 90% under UV light[47, 114]Silver nanoparticlesOxidative neutralization of algal toxins, reducing their toxicitySaxitoxin: oxidative degradation, detection limit ~ 1 ng/mL[115, 116]Graphene-based nanostructuresAdsorption and sequestration of neurotoxins, preventing bioaccumulationMicrocystin-LR: adsorption capacity ~ 50 mg/g[77]Activated carbon nanoparticlesEfficient binding and filtration of toxins from aquatic environmentsDomoic Acid: removal efficiency 85% in water samples[117] Table 4The following table outlines key nanomaterials utilized in neurotoxin neutralization:NanomaterialMechanism of neurotoxin mitigationExample neurotoxin & detection/mitigation rangeRefTitanium dioxide nanoparticlesPhotocatalytic degradation of neurotoxins under light exposureMicrocystin-LR: photocatalytic degradation efficiency 90% under UV light[47, 114]Silver nanoparticlesOxidative neutralization of algal toxins, reducing their toxicitySaxitoxin: oxidative degradation, detection limit ~ 1 ng/mL[115, 116]Graphene-based nanostructuresAdsorption and sequestration of neurotoxins, preventing bioaccumulationMicrocystin-LR: adsorption capacity ~ 50 mg/g[77]Activated carbon nanoparticlesEfficient binding and filtration of toxins from aquatic environmentsDomoic Acid: removal efficiency 85% in water samples[117] The following table outlines key nanomaterials utilized in neurotoxin neutralization: To visually clarify the synthesis strategies discussed, a detailed flowchart (Fig. 2) has been included to illustrate the core protocols used in nanomaterial development for neurotoxin mitigation. These schematic outlines five major approaches sol–gel synthesis, chemical reduction, chemical vapor deposition, physical activation, and green synthesis, each broken down into key steps and outcomes. These protocols lead to the formation of functional nanomaterials such as titanium dioxide, silver nanoparticles, graphene-based structures, activated carbon, and algae-mediated particles, all tailored for adsorption, degradation, or sequestration of aquatic neurotoxins. By mapping the progression from raw inputs to optimized nanostructures, the flowchart complements figuer 2 and enhances the reader’s understanding of how synthesis methodology directly influences performance in environmental applications.Fig. 2Flowchart of protocols for nanomaterial development in neurotoxin mitigation. The schematic illustrates five major synthesis routes sol‑gel processing, chemical reduction, chemical vapor deposition, physical activation, and green synthesis. Each protocol is shown with its key steps and representative outcomes, leading to nanomaterials such as titanium dioxide, silver nanoparticles, graphene‑based structures, activated carbon, and algae mediated particles. These methods collectively highlight how synthesis strategies influence adsorption, degradation, and sequestration properties critical for neutralizing aquatic neurotoxins. In the flowchart, the green tick (✔) indicates the advantages of each method, while the red cross (✘) denotes the disadvantages, providing a clear comparative view of their strengths and limitations Flowchart of protocols for nanomaterial development in neurotoxin mitigation. The schematic illustrates five major synthesis routes sol‑gel processing, chemical reduction, chemical vapor deposition, physical activation, and green synthesis. Each protocol is shown with its key steps and representative outcomes, leading to nanomaterials such as titanium dioxide, silver nanoparticles, graphene‑based structures, activated carbon, and algae mediated particles. These methods collectively highlight how synthesis strategies influence adsorption, degradation, and sequestration properties critical for neutralizing aquatic neurotoxins. In the flowchart, the green tick (✔) indicates the advantages of each method, while the red cross (✘) denotes the disadvantages, providing a clear comparative view of their strengths and limitations The application of these nanomaterials represents an innovative approach to reducing neurotoxin concentrations in marine ecosystems, addressing both environmental and public health concerns. Further research into the optimization of nanomaterial properties and ecological safety will enhance their effectiveness in real-world HAB mitigation efforts [118, 119]. Therapeutic and pharmacological potential of marine neurotoxins Exploration of neurotoxins as tools for neuroscience research Marine neurotoxins have emerged as critical tools in neuroscience research due to their ability to selectively target ion channels and neurotransmitter systems. These naturally occurring compounds, derived from marine algae and associated organisms, offer unique insights into neuronal function and have played a pivotal role in advancing the understanding of neurophysiology and neurodegenerative diseases [120, 121]. Historically, the use of neurotoxins in neuroscience dates back several decades, with tetrodotoxin isolated from pufferfish serving as one of the first molecular tools to dissect sodium channel function. Since then, marine algae-derived neurotoxins have become indispensable probes for investigating fundamental questions in neurobiology, ranging from synaptic transmission to neural network dynamics [122, 123]. From a mechanistic perspective, the utility of marine neurotoxins in neuroscience research stems from their exceptional binding affinity and specificity toward distinct classes of ion channels and receptors [123]. Unlike synthetic compounds that often exhibit off-target effects, these naturally evolved toxins have been refined through millions of years of evolutionary selection to interact with precise molecular targets. This specificity enables researchers to isolate and study individual components of the neuronal signaling apparatus without confounding variables introduced by non-selective pharmacological agents. The following subsections detail the specific contributions of the most widely studied marine neurotoxins to neuroscience research [124]. One of the primary applications of marine neurotoxins in neuroscience is their ability to modulate voltage-gated ion channels, which are essential for neuronal excitability and signal transmission. Saxitoxin and tetrodotoxin, both potent sodium channel blockers, have been extensively utilized in electrophysiological studies to investigate action potential propagation and nerve impulse regulation. These toxins bind to the pore region of voltage-gated sodium channels with nanomolar affinity, physically occluding sodium ion flow and thereby blocking depolarization. Different subtypes of sodium channels (Nav1.1 through Nav1.9) exhibit varying sensitivities to saxitoxin and tetrodotoxin, allowing researchers to determine which channel subtypes are expressed in specific neuronal populations and how they contribute to distinct physiological functions. Their specificity allows researchers to delineate the role of sodium channels in various physiological processes and neurological disorders, including epilepsy, chronic pain, and neurodegeneration [125, 126]. For example, the differential sensitivity of Nav1.8 channels to tetrodotoxin has enabled the identification of this subtype as a key mediator of inflammatory pain, leading to the development of selective Nav1.8 inhibitors now in clinical trials for pain management [127]. Domoic acid, another well-characterized marine neurotoxin, has been instrumental in studying excitotoxicity, a phenomenon linked to excessive glutamate receptor activation. This toxin mimics glutamate, leading to overstimulation of neurons and eventual cell death, closely mirroring pathological processes observed in Alzheimer’s disease and other forms of dementia. Specifically, domoic acid acts as a potent agonist of kainate receptors, a subclass of ionotropic glutamate receptors [128]. At nanomolar concentrations, domoic acid induces sustained receptor activation, resulting in prolonged calcium influx, mitochondrial dysfunction, generation of reactive oxygen species, and ultimately apoptotic or necrotic cell death. This molecular cascade recapitulates key features of excitotoxic neurodegeneration observed in conditions such as stroke, traumatic brain injury, and amyotrophic lateral sclerosis (ALS) [128, 129]. By using domoic acid-induced neurotoxicity as a model, researchers have explored potential neuroprotective strategies aimed at mitigating glutamate-induced neuronal damage [130, 131]. Preclinical studies utilizing domoic acid exposure have identified several promising neuroprotective agents, including calcium chelators, antioxidant compounds, and glutamate receptor antagonists, some of which have advanced to clinical evaluation for neurodegenerative diseases [132]. Beyond their use in basic research, marine neurotoxins have provided valuable insights into drug discovery and therapeutic intervention. Their highly specific interactions with neural receptors make them viable candidates for pharmacological refinement, particularly in the development of treatments for pain management, neuroinflammation, and neuromuscular disorders. In particular, the structure–activity relationships of saxitoxin and tetrodotoxin have guided medicinal chemistry efforts to develop non-addictive analgesics. By chemically modifying these neurotoxins to preferentially target peripheral sodium channels while reducing central nervous system penetration, researchers have produced analogs that maintain analgesic efficacy without the cardiorespiratory toxicity associated with the parent compounds. Several such derivatives are currently undergoing preclinical evaluation as long-acting local anesthetics for postoperative pain management [133]. The precise molecular mechanisms elucidated through neurotoxin studies continue to inform advancements in neuropharmacology, shaping innovative approaches to neurological therapeutics [134–136]. Furthermore, neurotoxin-based molecular tools have facilitated the discovery of previously unknown ion channel subtypes and the characterization of their distribution patterns across the central and peripheral nervous systems, knowledge that is essential for developing subtype-selective therapeutic agents [137]. In addition, several reports highlight the development of different types of nano-sensors designed to detect and analyze marine neurotoxins with high sensitivity. These include electrochemical nano-sensors (using nanostructured electrodes for saxitoxin detection), optical nano-sensors such as SPR and SERS platforms (employing gold nanoparticles for domoic acid analysis), carbon-based sensors (graphene and CNT systems for microcystin-LR), and algae-derived compound-integrated sensors (fucoidan, carrageenan, and peptides for enhanced biocompatibility) [95]. Each sensor type follows distinct development strategies but also faces practical limitations: electrochemical sensors require expensive electrode modifications, optical sensors depend on costly instrumentation, carbon-based sensors struggle with reproducibility at scale, and algae-derived sensors encounter stability and storage challenges [138]. A critical analysis reveals that while electrochemical sensors offer the advantage of portability and rapid response, their sensitivity is often compromised in complex biological matrices such as serum or cerebrospinal fluid [139]. Optical sensors provide superior sensitivity but require sophisticated infrastructure, limiting their deployment in resource-limited laboratory settings. Carbon-based sensors, despite their excellent electrical properties, suffer from batch-to-batch variability in nanomaterial synthesis, affecting assay reproducibility. Algae-derived sensors, while promising from a biocompatibility standpoint, face challenges related to the seasonal and geographical variability of algal biomass, which impacts the consistency of extracted biomolecules. An in-depth analysis of these nano-sensors demonstrates both their promise in advancing neurotoxin research and the practical limitations that must be addressed for real-world applications [140–145]. Utilization of nanocarriers for targeted delivery of marine neurotoxins in drug development The pharmacological potential of marine neurotoxins has garnered significant attention in drug development, particularly in the field of targeted drug delivery. While these compounds exhibit strong bioactivity, their potent effects necessitate controlled administration to minimize systemic toxicity. Nanotechnology presents a promising solution by enabling precise transport and release of neurotoxin-based therapeutics at specific biological targets, ensuring efficacy while mitigating adverse effects [146, 147]. To achieve selective delivery, modern nanocarrier systems incorporate a variety of targeting strategies. One widely used approach involves surface functionalization with targeting ligandssuch as peptides, antibodies, aptamers, folate, or transferring that bind specifically to receptors overexpressed on neuronal or glial cells [148]. These ligands guide nanocarriers toward diseased neural tissues, enhancing accumulation at the intended site while reducing systemic exposure. Biomimetic modifications represent another powerful strategy: coating nanoparticles with cell‑derived membranes (e.g., neuronal, macrophage, or stem‑cell membranes) enables immune evasion, prolonged circulation, and natural homing toward inflamed or degenerating neural regions [149]. Additionally, cell‑penetrating peptides (CPPs) and receptor‑mediated transcytosis motifs facilitate efficient crossing of biological barriers such as the blood–brain barrier, enabling neurotoxins to reach deep neural targets with high precision [150]. Together, these targeting mechanisms significantly improve the therapeutic index of marine neurotoxin‑based formulations by enhancing specificity, reducing off‑target toxicity, and enabling controlled pharmacological action [151]. Nanocarriers such as liposomes, polymeric nanoparticles, and lipid-based vesicles have been developed to encapsulate marine neurotoxins, enhancing their stability, bioavailability, and therapeutic specificity. Liposomal formulations, for instance, provide a protective lipid bilayer that shields neurotoxins from enzymatic degradation and premature clearance, allowing for sustained drug release. Polymeric nanoparticles offer controlled delivery mechanisms that regulate toxin release dynamics, ensuring prolonged pharmacological action while preventing abrupt fluctuations in bioavailability [152–154]. A particularly compelling area of research is the development of nano-enabled analgesics based on sodium channel-blocking neurotoxins such as saxitoxin and tetrodotoxin. Encapsulation of these compounds within biodegradable nanoparticles has demonstrated potential for localized pain relief, presenting an alternative to opioid-based medications. By targeting peripheral nerves while avoiding systemic neurotoxicity, these formulations offer a promising direction for non-addictive, long-duration pain management strategies [125, 155]. In addition to neurotoxin encapsulation, nanocarriers facilitate receptor-specific targeting, allowing for precision medicine approaches in neurology. Functionalized nanoparticles can be engineered to recognize and bind to neural receptors associated with neurodegenerative diseases, improving drug efficacy while reducing off-target effects. Continued advancements in nanocarrier technology are expected to refine delivery systems further, enhancing the pharmacokinetic properties of marine neurotoxin-based therapeutics [156, 157]. The integration of marine neurotoxins with nanotechnology marks a significant advancement in neuroscience and neuropharmacology, providing innovative solutions for neurological disorders and precision therapeutics. Future research efforts should focus on optimizing nanocarrier formulations and improving biocompatibility to fully harness the therapeutic potential of these marine-derived compounds [158]. Marine algae in nanotheranostics Role of marine algae-derived compounds in synthesizing nanoparticles for imaging and therapy Marine algae represent a valuable source of bioactive compounds with significant potential in the synthesis of nanoparticles for biomedical applications. These naturally derived biomolecules, including polysaccharides, proteins, and secondary metabolites, offer advantages such as biocompatibility, stability, and enhanced functional properties, making them ideal candidates for nanoparticle formulation [63, 159]. The growing interest in green nanotechnology has positioned marine algae as particularly attractive biofactories for nanomaterial synthesis, as they eliminate the need for toxic chemical reducing and capping agents traditionally used in conventional nanoparticle production methods [160]. Unlike chemically synthesized nanoparticles, which often require hazardous reagents such as sodium borohydride or hydrazine and generate environmental waste, algae-mediated synthesis offers a sustainable, cost-effective, and environmentally benign alternative. Furthermore, the inherent bioactivity of algae-derived compounds can impart additional therapeutic or targeting functionalities to the resulting nanoparticles, creating multifunctional platforms not achievable through purely synthetic approaches [3, 161]. From a mechanistic standpoint, the synthesis of nanoparticles using marine algae-derived compounds proceeds through three distinct phases: activation, growth, and termination. During the activation phase, bioactive molecules (primarily polysaccharides, peptides, and phenolic compounds) reduce metal ions (e.g., Ag⁺, Au3⁺, Fe2⁺/Fe3⁺) to their zero-valent metallic states through electron transfer reactions mediated by functional groups such as hydroxyl (-OH), carbonyl (C=O), and amine (-NH2) moieties. Simultaneously, these same biomolecules serve as capping agents, adsorbing onto the nascent nanoparticle surface and preventing uncontrolled aggregation. In the growth phase, additional metal ions diffuse to the surface of the nucleated particles, where further reduction occurs, leading to particle size enlargement. The termination phase occurs when the capping agents fully passivate the nanoparticle surface, halting further growth. The size, shape, and crystallinity of the resulting nanoparticles are determined by the specific algal species used, the concentration of precursor metal ions, pH, temperature, and reaction time, allowing for controlled synthesis of nanoparticles with desired physicochemical properties [3, 63, 159]. In imaging applications, algae-derived nanoparticles are used across multiple environments, including in vitro cellular imaging, in vivo preclinical imaging, and environmental biosensing. Their imaging performance is based on several principles: (i) optical imaging, where algal pigments or metal enhanced nanoparticles generate fluorescence or luminescence signals; (ii) magnetic resonance imaging (MRI), where algae‑mediated synthesis of iron oxide nanoparticles provides strong T1/T2 contrast; (iii) photoacoustic imaging, in which nanoparticles absorb near infrared light and convert it into acoustic waves for deep tissue visualization; and (iv) computed tomography (CT) or X-ray imaging, where high atomic number nanoparticles (e.g., Au, Ag) synthesized using algal extracts enhance radiographic contrast. These imaging mechanisms enable improved signal intensity, deeper tissue penetration, and enhanced spatial resolution, supporting applications in tumor localization, vascular imaging, and real‑time tracking of therapeutic delivery [162–164]. A comparative evaluation reveals that algae-synthesized imaging nanoparticles often outperform chemically synthesized counterparts in terms of biocompatibility and reduced immunogenicity. For instance, iron oxide nanoparticles synthesized using Sargassum extract exhibit comparable or superior T2 relaxivity to conventionally prepared agents while demonstrating significantly lower cytotoxicity in neuronal cell lines. However, challenges remain in achieving consistent size distribution and crystallinity across different algal batches, factors that critically influence imaging performance reproducibility. Current research is addressing these limitations through optimization of extraction protocols, standardization of reaction parameters, and development of post-synthetic purification methods [165–167]. One of the primary applications of marine algae in nanomedicine is their role in facilitating the synthesis of metal-based and polymeric nanoparticles for imaging and therapeutic interventions. Algal polysaccharides, such as fucoidan and carrageenan, act as stabilizing and capping agents in nanoparticle synthesis, ensuring controlled size distribution and improved biocompatibility. The ability of these biomolecules to enhance nanoparticle stability and reduce toxicity makes them particularly suitable for targeted drug delivery and contrast-enhanced imaging techniques in biomedical diagnostics [168–170]. Fucoidan-based nanoparticles have demonstrated selective uptake by macrophages and cancer cells due to the interaction of fucoidan with P-selectin and scavenger receptors, which are overexpressed on activated endothelial cells and various tumor types. This receptor-mediated targeting capability enables passive and active accumulation of fucoidan-coated nanoparticles at diseased sites, reducing off-target distribution and enhancing therapeutic indices. Carrageenan, with its negative surface charge, facilitates electrostatic interactions with positively charged cell membranes and has been successfully incorporated into mucoadhesive drug delivery systems for ophthalmic and oral administration. Notably, carrageenan-based nanoparticles have shown enhanced permeability and retention (EPR) effect-mediated tumor accumulation in preclinical models, achieving up to 3.5-fold higher tumor drug concentrations compared to uncoated controls [171, 172]. In addition to their structural function, marine algae-derived compounds exhibit intrinsic therapeutic properties that further expand their utility in nanotheranostics. For example, bioactive molecules extracted from Ulva and Sargassum species possess antioxidant and anti-inflammatory effects, contributing to nanoparticle-mediated therapeutic strategies. These compounds have been explored for their potential in cancer therapy, where nanoparticle formulations improve drug targeting while minimizing adverse effects on healthy tissues[63, 173, 174]. Specifically, ulvan (a sulfated polysaccharide from Ulva) exhibits immunomodulatory activity through activation of Toll-like receptor 4 (TLR4) and promotes macrophage polarization toward the antitumor M1 phenotype. Sargassum-derived fucoidan has been shown to induce apoptosis in various cancer cell lines via caspase-3 and caspase-9 activation while simultaneously inhibiting angiogenesis through downregulation of vascular endothelial growth factor (VEGF). When incorporated into nanoparticle platforms, these intrinsic therapeutic effects synergize with encapsulated chemotherapeutic agents, enabling combination therapy approaches that may overcome drug resistance mechanisms. Furthermore, the antioxidant properties of these compounds (demonstrated by DPPH radical scavenging and ferric reducing antioxidant power (FRAP) assays) can mitigate the oxidative stress induced by certain chemotherapeutic agents, potentially reducing treatment-related toxicities in normal tissues [175, 176]. Despite the considerable promise of algae-mediated nanoparticle synthesis, several challenges impede clinical translation. Scale-up from laboratory-scale batch synthesis (milligrams to grams) to industrial-scale production (kilograms) remains technically challenging, as reaction conditions optimized for small volumes often fail to yield consistent nanoparticle properties at larger scales[177]. Regulatory approval pathways for algae-derived nanomaterials are not yet well-established, as existing frameworks were designed for synthetically produced nanoparticles and do not fully accommodate the inherent batch-to-batch variability of biologically sourced materials nt batch-to-batch variability of biologically sourced materials [178]. Furthermore, comprehensive toxicity studies evaluating long-term biodistribution, degradation, and clearance of algae-synthesized nanoparticles are currently lacking. Addressing these knowledge gaps requires interdisciplinary collaboration among marine biologists, nanochemists, materials scientists, and regulatory toxicologists. Future research priorities should include: (i) development of continuous flow synthesis systems for reproducible large-scale production; (ii) establishment of standardized quality control metrics specific to algae-derived nanomaterials; (iii) comprehensive in vivo toxicokinetic and long-term safety studies in relevant animal models; and (iv) investigation of the fate of algal biomolecules within biological systems to identify potential immunogenic or off-target effects [179]. The integration of marine algae-derived components into nanoparticle synthesis not only enhances the functional properties of nanomaterials but also aligns with the growing demand for environmentally sustainable and biologically compatible alternatives in biomedical applications [180]. Application of marine neurotoxins in theranostic platforms combining diagnostics and treatment The unique biochemical properties of marine neurotoxins have positioned them as promising candidates for theranostic applications, where diagnostic and therapeutic functions are combined within a single platform. These potent bioactive compounds, traditionally associated with toxicological concerns, are now being explored for their potential in targeted treatment strategies for neurological disorders, pain management, and cancer therapy [146, 181]. For example, One emerging application involves the use of neurotoxin-based nanoparticles for precision imaging of neurodegenerative conditions [182]. Certain neurotoxins, such as saxitoxin and brevetoxins, exhibit strong affinities for neuronal receptors, enabling selective interaction with diseased neural tissues. When conjugated with nanoparticles designed for imaging, these neurotoxins enhance diagnostic precision, facilitating early detection of neurological disorders such as Alzheimer's disease and multiple sclerosis [182, 183]. The development of theranostic platforms incorporating marine neurotoxins underscores the growing interdisciplinary focus on nanomedicine, neuropharmacology, and toxin-based therapeutics. Continued research into optimizing these systems will be essential for translating neurotoxin-based nanotechnology into clinical applications while ensuring safety and efficacy in human health interventions [183]. Future perspectives Potential research directions at the intersection of marine algae and nanotechnology The convergence of marine algae and nanotechnology presents an emerging frontier with significant implications for biomedicine, environmental sustainability, and material sciences. While substantial progress has been made in harnessing marine algae-derived compounds for nanomaterial synthesis, several areas require further exploration to maximize their potential applications [180]. One key direction involves refining algae-based nanocarriers for targeted drug delivery. The development of nanoparticles functionalized with marine algae-derived biomolecules may improve drug bioavailability, reduce systemic toxicity, and enhance therapeutic efficacy. By integrating biologically active compounds from algae, researchers can explore their role in modulating nanocarrier interactions with diseased tissues, potentially enabling site-specific therapeutic interventions for neurodegenerative diseases, cancer, and antimicrobial treatments [184, 185]. The environmental applications of marine algae‑derived nanomaterials are another promising avenue. Algae‑based nanoparticles have demonstrated potential in water purification and pollutant remediation due to their natural adsorptive properties. Further studies should investigate the optimization of these materials to enhance their efficiency in removing heavy metals, organic pollutants, and harmful algal toxins from aquatic ecosystems. Understanding how structural modifications influence their interaction with contaminants will be essential for their large-scale deployment in sustainable environmental management [63, 186]. Additionally, integrating marine neurotoxins into nanotechnology platforms offers new possibilities in biomedical imaging and theranostics. Some neurotoxins exhibit specificity for neuronal receptors, making them potential candidates for precision diagnostics in neurological disorders. Future research should focus on engineering nanoparticle formulations that stabilize and regulate neurotoxin activity, ensuring their controlled use in targeted imaging systems and therapeutics [187, 188]. While these research directions provide exciting opportunities, interdisciplinary collaboration will be fundamental to translating laboratory findings into practical applications. Advancements in nanobiotechnology, materials science, and marine biology must intersect to refine methodologies and ensure the safe and effective use of algae-derived nanomaterials. To guide future research, a comparative overview of reported studies has been provided in Table 5. This table highlights the advantages and disadvantages of different approaches, including HAB monitoring strategies, neurotoxin pharmacology, nano‑biosensor development, and the integration of algae‑derived compounds into nanomaterials. By synthesizing detection limits, performance outcomes, and practical challenges, the table not only summarizes the current state of knowledge but also underscores where innovation is most needed. Linking these insights with the proposed research directions ensures that future work can build on existing strengths while addressing limitations, ultimately accelerating the translation of marine algae–nanotechnology applications into real‑world solutions.Table 5Comparative overview of reported studies and their advantages and disadvantagesFocus AreaExample study / TargetReported data (Detection limit / Impact)AdvantagesDisadvantagesReferencesHABs monitoringChlorophyll-a thresholds for bloom detection10 µg/L chlorophyll-a; cell density 106 cells/LSimple proxy, widely usedNon-specific, may miss toxin presence[189, 190]Economic impact of HABsFisheries & aquaculture lossesBillions annually in closures & healthcare costsHighlights societal relevanceData varies regionally, hard to generalize[191, 192]Neurotoxin pharmacologySaxitoxin, brevetoxin, domoic acidSTX: sodium channel blocker; DA: glutamate agonistHigh specificity, research toolsSevere toxicity, limited safe use[146, 193]Nano-biosensorsSTX, DA, Botulinum toxinSTX: 0.5–5 nM; DA: 0.1 nM; BoNT: femtomolar10–1000 × more sensitive than ELISA/HPLCDevice cost, stability issues[194]Integration of algae-derived compoundsFucoidan, carrageenan, alginate, peptidesMC-LR: 0.05 ng/mL (fucoidan); TTX: ~ 1 ng/mL (peptides); STX: ~ 0.5 ng/mL (phycobiliproteins)Biocompatibility, improved binding, stabilityExtraction complexity, variability[195, 196]Theranostics& NanomedicineNeurotoxin-loaded nanocarriersControlled release, imaging, precision targetingEnables dual therapy/diagnosticsEthical concerns, toxicity risk[197, 198] Table 5Comparative overview of reported studies and their advantages and disadvantagesFocus AreaExample study / TargetReported data (Detection limit / Impact)AdvantagesDisadvantagesReferencesHABs monitoringChlorophyll-a thresholds for bloom detection10 µg/L chlorophyll-a; cell density 106 cells/LSimple proxy, widely usedNon-specific, may miss toxin presence[189, 190]Economic impact of HABsFisheries & aquaculture lossesBillions annually in closures & healthcare costsHighlights societal relevanceData varies regionally, hard to generalize[191, 192]Neurotoxin pharmacologySaxitoxin, brevetoxin, domoic acidSTX: sodium channel blocker; DA: glutamate agonistHigh specificity, research toolsSevere toxicity, limited safe use[146, 193]Nano-biosensorsSTX, DA, Botulinum toxinSTX: 0.5–5 nM; DA: 0.1 nM; BoNT: femtomolar10–1000 × more sensitive than ELISA/HPLCDevice cost, stability issues[194]Integration of algae-derived compoundsFucoidan, carrageenan, alginate, peptidesMC-LR: 0.05 ng/mL (fucoidan); TTX: ~ 1 ng/mL (peptides); STX: ~ 0.5 ng/mL (phycobiliproteins)Biocompatibility, improved binding, stabilityExtraction complexity, variability[195, 196]Theranostics& NanomedicineNeurotoxin-loaded nanocarriersControlled release, imaging, precision targetingEnables dual therapy/diagnosticsEthical concerns, toxicity risk[197, 198] Comparative overview of reported studies and their advantages and disadvantages Strategies for overcoming ethical and environmental challenges Despite the transformative potential of marine algae-based nanotechnology, several ethical and environmental considerations must be addressed to ensure responsible implementation. A major concern is the sustainability of algae harvesting, particularly in fragile marine ecosystems. The large-scale extraction of bioactive compounds for nanomaterial production could disrupt ecological balance and threaten biodiversity. Therefore, Developing controlled cultivation strategies, such as microalgae bioreactors and closed-loop aquaculture systems, may mitigate these risks by reducing dependence on wild algae populations while ensuring consistent yields [199, 200]. Another ethical challenge pertains to the safe deployment of marine neurotoxins in biomedical applications. While these compounds hold promise for targeted drug delivery and theranostic platforms, their inherent toxicity necessitates stringent regulatory oversight [201]. Consequently, Future studies should prioritize the development of biocompatible nanocarriers that enable controlled neurotoxin release while minimizing unintended biological interactions. In addition, Establishing standardized toxicity assessments and conducting long-term safety evaluations will be crucial in determining their suitability for clinical applications [202, 203]. Furthermore, concerns regarding the environmental impact of nanotechnology must be carefully considered. The potential accumulation of synthetic nanoparticles in ecosystems raises questions about their long-term effects on marine life and human health [204]. However, The design of biodegradable and eco-friendly nanomaterials derived from marine algae offers a viable solution to minimize these risks. Researchers should focus on engineering nanoparticles that degrade naturally without leaving harmful residues, ensuring their safe integration into medical, industrial, and environmental processes [205]. The ethical and regulatory landscape surrounding algae-based nanotechnology must evolve alongside scientific advancements. Therefore, Collaborative frameworks involving researchers, policymakers, and industry stakeholders will be necessary to establish guidelines that balance innovation with sustainability [206]. Furthermore, Emphasizing transparency, ecological responsibility, and equitable access to emerging technologies will ultimately shape the future of marine algae-derived nanomaterials as a viable solution for global health and environmental challenges [207]. Conclusion This review has synthesized current knowledge on harmful algal blooms (HABs), marine algae‑derived neurotoxins, and their integration into nanotechnology platforms. HABs remain a pressing ecological and economic challenge, with cell densities exceeding 10^6 cells/L and chlorophyll-a thresholds above 10 µg/L serving as critical indicators of bloom events. Reported studies highlight their severe impacts on marine ecosystems, fisheries, and public health, with annual economic losses reaching billions worldwide. Marine algae-derived neurotoxins such as saxitoxin, brevetoxin, and domoic acid, while hazardous in uncontrolled contexts, have demonstrated unique biochemical properties that make them valuable tools in neuroscience and pharmacology. Their ability to selectively modulate ion channels and receptors has opened new avenues for biomedical research, particularly in modeling neurological disorders. Nanotechnology provides a powerful framework for utilizing marine algae‑derived compounds in a safe and controlled manner. Recent advances in nano‑biosensors have pushed detection capabilities to unprecedented levels, with sensitivities reaching nanomolar and even femtomolar ranges representing improvements of one to three orders of magnitude compared to conventional assays. Studies have further shown that biomolecules such as fucoidan, carrageenan, alginate, peptides, and phycobiliproteins can be incorporated into nanomaterials to enhance sensor stability, biocompatibility, and analytical precision. Table 5 offers a comparative overview of these reported studies, outlining both their strengths and limitations to provide a consolidated perspective on current progress. From our analysis, the intersection of marine biology and nanotechnology emerges as a promising frontier with broad implications. While notable strides have been made in biosensing, theranostics, and environmental monitoring, persistent challenges remainparticularly in terms of scalability, reproducibility, and long‑term safety. Moving forward, research should prioritize the refinement of algae-based nanocarriers for targeted drug delivery, the optimization of algae‑derived nanomaterials for pollutant remediation, and the design of neurotoxin‑integrated nanoplatforms for precision diagnostics. Therefore, achieving these goals will need close teamwork across disciplines, ensuring that laboratory innovations can be translated into practical solutions for both ecological sustainability and biomedical advancement.